What is VivaQuant?
VivaQuant operates within the digital healthcare sector, specializing in remote cardiac monitoring solutions delivered under its Rhythm Express brand. The company's core offering is a differentiated mobile cardiac telemetry (MCT) wearable, designed for comfort and extended use of up to 30 days. This device is engineered to provide near real-time observation of patient heart rhythms, boasting proprietary noise-canceling algorithms for high-clarity ECGs and machine learning-enabled wavelet analytics for precise arrhythmia identification. This technological foundation facilitates rapid diagnosis and supports physicians in developing critical, life-saving care plans through 24/7/365 oversight of patient data.
How much funding has VivaQuant raised?
VivaQuant has raised a total of $69K across 1 funding round:
Debt
$69K
Debt (2021): $69K with participation from PPP
What's next for VivaQuant?
With the recent substantial expansion capital, VivaQuant is poised for significant scaling. The company's focus will likely be on enhancing its technological capabilities, expanding its service offerings, and increasing market penetration within hospitals and clinics. Strategic investments may target further development of its AI-driven analytics, broadening the application of its wearable technology, and strengthening its sales and support infrastructure to meet growing demand for advanced remote patient monitoring solutions in the healthcare industry.
See full VivaQuant company page
